MindMed (MNMD.Q) announced they are appointing Dr. Maurizio Fava to their Scientific Advisory Board. Dr. Fava obtained his medical doctorate from the University of Padova School of Medicine, and went…
MNMD.Q
Mind Medicine (MNMD.Q) announced the addition of Dr. Peter Bergethon to their Scientific Advisory Board. Bergethon is a “world-leading” expert in neurology, digital medicine, and central nervous system (CNS)…
Mind Medicine (MMED.NE, MNMD.Q) announced that J.R. Rahn is stepping down from his roles as CEO and director. Rahn was a co-founder of the company and was at the…
Early money Earlier this week California introduced a bill to decriminalize psychedelics. If passed, SB 519 will approve the use of mushrooms, MDMA, LSD, mescaline, and ibogaine for…
In a groundbreaking story MindMed (MNMD.Q) announced today has been granted approval by the Swiss Ethics Committee to evaluate the acute effects of different doses of mescaline and the…